Largest biotech companies in the United States by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 10 biotech companies in the United States ranked by total debt, at NOK 533.3B, ahead of Gilead Sciences (NOK 243.5B) and Biogen (NOK 61.4B). Figures as of 20 Nov 2026, 18:16 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
10
First
AmgenNOK 533.3B
Median
NOK 5.5B
Combined market value
NOK 7.17T
Countries
1
Not ranked
10no total debt on file

Market values as of .

United States
All sectors
Biotech
NOK
Clear filters
Largest biotech companies in the United States by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareNOK 533.3BNOK 2.32TNOK 4,288.77 0.65% up 30% up United States
2Gilead SciencesGILD · Health CareNOK 243.5BNOK 2.04TNOK 1,646.55 1.24% up 31% up United States
3BiogenBIIB · Health CareNOK 61.4BNOK 360.7BNOK 2,439.84 1.09% up 41% up United States
4Halozyme TherapeuticsHALO · Health CareNOK 20.9BNOK 103.5BNOK 907.64 0.11% down 32% up United States
5ModernaMRNA · Health CareNOK 5.8BNOK 768.2BNOK 1,898.69 2.47% down 740% up United States
6RepligenRGEN · Health CareNOK 5.3BNOK 103.3BNOK 1,616.53 2.80% down 5% up United States
7Bio-TechneTECH · Health CareNOK 2BNOK 111.6BNOK 710.21 0.03% up 18% up United States
8Adaptive BiotechnologiesADPT · Health CareNOK 1.3BNOK 44BNOK 271.80 0.78% down 51% up United States
9Scholar Rock HoldingSRRK · Health CareNOK 973.8MNOK 59.7BNOK 489.39 0.52% down 25% up United States
10CG OncologyCGON · Health CareNOK 29.3MNOK 70.4BNOK 788.05 1.48% down 93% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7664 NOK). 10 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech companies in the United States rank first by total debt?

Amgen (NOK 533.3B), Gilead Sciences (NOK 243.5B) and Biogen (NOK 61.4B) are the top three of the 10 biotech companies in the United States ranked by total debt as of 20 Nov 2026, 18:16 UTC.

How many biotech companies in the United States are in this ranking?

10 are ranked by total debt. 10 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech companies in the United States worth together?

The 10 biotech companies in the United States ranked by total debt have a combined market value of NOK 7.17T as of 20 Nov 2026, 18:16 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech companies in the United States by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.